As Sanofi counts down the days before its new leader arrives, the French pharma’s interim CEO acknowledged there had been a ...
[Interpreted] [Operator Instructions] We'd like to start the presentation with Chris. We'd like to cover the business highlight, followed by Maeda to give the highlights of the Japanese business, and ...
The wait is over. Fierce Biotech has released its annual ranking of the top 10 pharma R&D budgets of 2025—offering a clear look at which companies are spending the most on innovation and how those ...
In 2023, Johnson & Johnson announced it had stopped research and development on therapeutics for many infectious diseases, including hepatitis and tuberculosis. Less visibly, AbbVie shuttered last ...
AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs. The R ...
DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical R&D Outsourcing Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Pharmaceutical R&D Outsourcing Market ...
Popular diabetes and weight-loss drugs known as GLP-1s are helping to boost the biopharma sector's return on investment this year, according to a new report from consulting firm Deloitte. Companies ...
Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, making the pharmaceutical giant the latest company to unveil a capital ...
AI will be a useful tool in reducing R&D costs to help alleviate some of the pain pharma will feel by the imminent patent cliff. Speaking at Arena International’s Clinical Data Management Innovation ...
Kirti Ganorkar, MD of Sun Pharmaceutical Industries, said the company will continue investing in R&D while using Organon’s ...
Though Merck’s 2024 R&D spending plummeted by almost $13 billion compared to 2023, the New Jersey pharma still came in $700 million ahead of its closest competitor, Johnson & Johnson. Merck's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results